학술논문
Rare Germline Variants in ATMPredispose to Prostate Cancer: A PRACTICAL Consortium Study
Document Type
Article
Author
Karlsson, Questa; Brook, Mark N.; Dadaev, Tokhir; Wakerell, Sarah; Saunders, Edward J.; Muir, Kenneth; Neal, David E.; Giles, Graham G.; MacInnis, Robert J.; Thibodeau, Stephen N.; McDonnell, Shannon K.; Cannon-Albright, Lisa; Teixeira, Manuel R.; Paulo, Paula; Cardoso, Marta; Huff, Chad; Li, Donghui; Yao, Yu; Scheet, Paul; Permuth, Jennifer B.; Stanford, Janet L.; Dai, James Y.; Ostrander, Elaine A.; Cussenot, Olivier; Cancel-Tassin, Géraldine; Hoegel, Josef; Herkommer, Kathleen; Schleutker, Johanna; Tammela, Teuvo L.J.; Rathinakannan, Venkat; Sipeky, Csilla; Wiklund, Fredrik; Grönberg, Henrik; Aly, Markus; Isaacs, William B.; Dickinson, Jo L.; FitzGerald, Liesel M.; Chua, Melvin L.K.; Nguyen-Dumont, Tu; Schaid, Daniel J.; Southey, Melissa C.; Eeles, Rosalind A.; Kote-Jarai, Zsofia
Source
European Urology Oncology; August 2021, Vol. 4 Issue: 4 p570-579, 10p
Subject
Language
ISSN
25889311
Abstract
Germline ATMmutations are suggested to contribute to predisposition to prostate cancer (PrCa). Previous studies have had inadequate power to estimate variant effect sizes.